Clinical Medicine
Listando 36 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
385
Twitter
0
Wikipedia
50
News
0
Policy
Article
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
Kalinsky, Kevin; Barlow, William E.; Gralow, Julie R.; Meric-Bernstam, Funda; Albain, Kathy S.; Hayes, Daniel F.; Lin, Nancy U.; Perez, Edith A.; Goldstein, Lori J.; Chia, Stephen K. L.; Dhesy-Thind, Sukhbinder; Rastogi, Priya; Alba, Emilio; Delaloge, Suze
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2021)
DOI /
10.1056/nejmoa2108873
Mentions
48
Twitter
0
Wikipedia
60
News
0
Policy
Article
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial
Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30021-9
Mentions
73
Twitter
0
Wikipedia
37
News
0
Policy
Article
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx647
Bronze
Mentions
74
Twitter
0
Wikipedia
34
News
0
Policy
Article
Trajectories of alcohol consumption during life and the risk of developing breast cancer
Donat-Vargas, Carolina; Guerrero-Zotano, Angel; Casas, Ana; Manuel Baena-Canada, Jose; Lope, Virginia; Antolin, Silvia; Angel Garcia-Saenz, Jose; Bermejo, Begona; Munoz, Montserrat; Ramos, Manuel; de Juan, Ana; Jara Sanchez, Carlos; Sanchez-Rovira, Pedro;
BRITISH JOURNAL OF CANCER
0007-0920 (2021)
DOI /
10.1038/s41416-021-01492-w
Hybrid
Mentions
231
Twitter
0
Wikipedia
0
News
0
Policy
Article
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomas; Oliveira, Mafalda; Pernas, Sonia; Pare, Laia; Escriva-de-Romani, Santiago; Manso, Luis; Adamo, Barbara; Martinez, Eduardo; Cortes, Javier; Vazquez, Silvia; Perello, Antonia; Garau, Isabel; Mele, Mireia;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-0844
Mentions
1
Twitter
0
Wikipedia
9
News
0
Policy
Article
Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis
Jimenez Rodriguez, Begona; Diaz Cordoba, Gema; Garrido Aranda, Alicia; Alvarez, Martina; Vicioso, Luis; Llacer Perez, Casilda; Hernando, Cristina; Bermejo, Begona; Julve Parreno, Ana; Lluch, Ana; Ryder, Matthew B.; Jones, Frederick S.; Fredebohm, Johannes;
JOURNAL OF CLINICAL MEDICINE
(2019)
DOI /
10.3390/jcm8081183
Gold DOAJ, Green published
Mentions
50
Twitter
0
Wikipedia
5
News
0
Policy
Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Prat, Aleix; Pascual, Tomas; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortes, Javier; Rexer, Brent; Pare, Laia; Forero, Andres; Wolff, Antonio C.; Morales, Serafin; Adamo, Barbara; Braso-Maristany, Fara; Vidal, Maria;
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
0027-8874 (2020)
DOI /
10.1093/jnci/djz042
Green published, Bronze
Mentions
51
Twitter
0
Wikipedia
7
News
0
Policy
Article
Chemotherapy de-escalation using an F-18-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
Manuel Perez-Garcia, Jose; Gebhart, Geraldine; Ruiz Borrego, Manuel; Stradella, Agostina; Bermejo, Begona; Schmid, Peter; Marme, Frederik; Escriva-de-Romani, Santiago; Calvo, Lourdes; Ribelles, Nuria; Martinez, Noelia; Albacar, Cinta; Prat, Aleix; Dalenc,
LANCET ONCOLOGY
1470-2045 (2021)
DOI /
10.1016/s1470-2045(21)00122-4
Mentions
12
Twitter
0
Wikipedia
5
News
0
Policy
Article
Physical activity and breast cancer risk by pathological subtype
Lope, Virginia; Martin, Miguel; Castello, Adela; Casla, Soraya; Ruiz, Amparo; Manuel Baena-Canada, Jose; Ma Casas, Ana; Calvo, Lourdes; Bermejo, Begona; Munoz, Montserrat; Ramos, Manuel; De Juan-Ferre, Ana; Jara, Carlos; Anton, Antonio; Angeles Jimeno, Ma;
GYNECOLOGIC ONCOLOGY
0090-8258 (2017)
DOI /
10.1016/j.ygyno.2016.12.014
Mentions
55
Twitter
0
Wikipedia
2
News
0
Policy
Article
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)
Lopez-Tarruella, Sara; Escudero, M. J.; Pollan, Marina; Martin, Miguel; Jara, Carlos; Bermejo, Begona; Guerrero-Zotano, Angel; Garcia-Saenz, Jose; Santaballa, Ana; Alba, Emilio; Andres, Raquel; Martinez, Purificacion; Calvo, Lourdes; Fernandez, Antonio; Ba
SCIENTIFIC REPORTS
2045-2322 (2019)
DOI /
10.1038/s41598-019-55765-9
Gold DOAJ, Green published
Mentions
85
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael
NATURE COMMUNICATIONS
(2020)
DOI /
10.1038/s41467-019-14111-3
Gold DOAJ, Green published
Mentions
36
Twitter
0
Wikipedia
4
News
0
Policy
Article
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL
Martin, M.; Zielinski, C.; Ruiz-Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, E. M.; Munoz, M.; Bermejo, B.; Margeli, M.; Anton, A.; Kahan, Z.; Csoszi, T.; Casas, M., I; Murillo, L.; Morales, S.; Alba, E.; Gal-Yam, E.; Guerrero-Zotano, A.; Calvo, L.; de
ANNALS OF ONCOLOGY
0923-7534 (2021)
DOI /
10.1016/j.annonc.2020.12.013
Green published, Gold other
Mentions
41
Twitter
0
Wikipedia
2
News
0
Policy
Article
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial A Randomized Phase 3 Clinical Trial
Gianni, Luca; Mansutti, Mauro; Anton, Antonio; Calvo, Lourdes; Bisagni, Giancarlo; Bermejo, Begona; Semiglazov, Vladimir; Thill, Marc; Ignacio Chacon, Jose; Chan, Arlene; Morales, Serafin; Alvarez, Isabel; Plazaola, Arrate; Zambetti, Milvia; Redfern, Andre
JAMA ONCOLOGY
2374-2437 (2018)
DOI /
10.1001/jamaoncol.2017.4612
Green published, Bronze
Mentions
25
Twitter
0
Wikipedia
1
News
0
Policy
Article
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study
Fernandez de Larrea-Baz, Nerea; Perez-Gomez, Beatriz; Guerrero-Zotano, Angel; Maria Casas, Ana; Bermejo, Begona; Manuel Baena-Canada, Jose; Antolin, Silvia; Sanchez-Rovira, Pedro; Ramos Vazquez, Manuel; Angel Garcia-Saenz, Jose; Anton, Antonio; Munoz, Mont
SCIENTIFIC REPORTS
2045-2322 (2020)
DOI /
10.1038/s41598-020-63637-w
Green published, Gold other
Mentions
47
Twitter
0
Wikipedia
0
News
0
Policy
Article
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer
Pascual, Tomas; Cejalvo, Juan M.; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begona; de la Cruz-Merino, Luis; Juan, Manel; Ferrero-Cafiero, Juan M.; Canes, Jordi; Gonzal
FUTURE ONCOLOGY
1479-6694 (2020)
DOI /
10.2217/fon-2020-0246
Mentions
5
Twitter
0
Wikipedia
3
News
0
Policy
Article
F-18-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial
Quintela-Fandino, Miguel; Lluch, Ana; Manso, Luis; Calvo, Isabel; Cortes, Javier; Angel Garcia-Saenz, Jose; Gil-Gil, Miguel; Martinez-Janez, Noelia; Gonzalez-Martin, Antonio; Adrover, Encarna; de Andres, Raquel; Vinas, Gemma; Llombart-Cussac, Antonio; Alba
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-16-0738
Bronze
Mentions
2
Twitter
0
Wikipedia
3
News
0
Policy
Article
Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study
Kahan, Zsuzsanna; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Casas, Maribel; Csoszi, Tibor; Murillo, Laura; Morales, Serafin; Calvo, Lourdes; Lang, Istvan; Alba,
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.07.004
Hybrid
Mentions
41
Twitter
0
Wikipedia
0
News
0
Policy
Article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, A
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00351-4
Gold
Mentions
36
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon,
NPJ PRECISION ONCOLOGY
(2021)
DOI /
10.1038/s41698-021-00163-6
Gold DOAJ
Mentions
11
Twitter
0
Wikipedia
1
News
0
Policy
Article
Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer
Adam-Artigues, A.; Simon, S.; Ortega, B.; Moragon, S.; Lameirinhas, A.; Salta, S.; Burgues, O.; Bermejo, B.; Henrique, R.; Lluch, A.; Jeronimo, C.; Eroles, P.; Cejalvo, J. M.
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2020.100039
Green published, Gold
Mentions
33
Twitter
0
Wikipedia
0
News
0
Policy
Article
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer
Nunez-Torres, Rocio; Martin, Miguel; Garcia-Saenz, Jose Angel; Rodrigo-Faus, Maria; del Monte-Millan, Maria; Tejera-Perez, Hugo; Pita, Guillermo; de la Torre-Montero, Julio C.; Pinilla, Karen; Herraez, Belen; Peiro-Chova, Lorena; Bermejo, Begona; Lluch, An
JAMA DERMATOLOGY
2168-6068 (2020)
DOI /
10.1001/jamadermatol.2020.1867
Mentions
7
Twitter
0
Wikipedia
1
News
0
Policy
Article
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Quintela-Fandino, Miguel; Holgado, Esther; Manso, Luis; Morales, Serafin; Bermejo, Begona; Colomer, Ramon; Apala, Juan V.; Blanco, Raquel; Munoz, Manuel; Caleiras, Eduardo; Iranzo, Vega; Martinez, Mario; Dominguez, Orlando; Hornedo, Javier; Gonzalez-Cortij
BREAST CANCER RESEARCH
1465-542X (2020)
DOI /
10.1186/s13058-020-01362-y
Gold, Green published
Mentions
2
Twitter
0
Wikipedia
1
News
0
Policy
Article
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Gavila, J.; de la Haba, J.; Bermejo, B.; Rodriguez-Lescure, A.; Anton, A.; Ciruelos, E.; Brunet, J.; Munoz-Couselo, E.; Santisteban, M.; Rodriguez Sanchez, C. A.; Santaballa, A.; Sanchez Rovira, P.; Garcia Saenz, J. A.; Ruiz-Borrego, M.; Guerrero-Zotano, A
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-019-02145-4
Mentions
12
Twitter
0
Wikipedia
0
News
0
Policy
Article
High Numbers of Circulating CD57(+) NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2(+) Primary Breast Cancer
Muntasell, Aura; Servitja, Sonia; Cabo, Mariona; Bermejo, Begona; Perez-Buira, Sandra; Rojo, Federico; Costa-Garcia, Marcel; Arpi, Oriol; Moraru, Manuela; Serrano, Laia; Tusquets, Ignasi; Teresa Martinez, Maria; Heredia, Gemma; Vera, Andrea; Martinez-Garci
CANCER IMMUNOLOGY RESEARCH
2326-6066 (2019)
DOI /
10.1158/2326-6066.cir-18-0896
Bronze
Mentions
13
Twitter
0
Wikipedia
0
News
0
Policy
Article
Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
Bellver, Gemma; Buch, Elvira; Ripoll, Francisco; Adrianzen, Marcos; Bermejo, Begona; Burgues, Octavio; Julve, Ana; Ortega, Joaquin
JOURNAL OF SURGICAL RESEARCH
(2021)
DOI /
10.1016/j.jss.2021.10.006
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, Ana C.; Saura, Cristina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begona; Gavila, Joaquin; Serra, Violeta; Prat, Aleix; Pare, Laia; Celiz, Pamela; Villagrasa, Patricia; Li, Yisheng; Savoie, Jennifer; Xu, Zhan; Arteaga, Car
BREAST CANCER RESEARCH
1465-542X (2020)
DOI /
10.1186/s13058-020-01354-y
Gold DOAJ, Green published
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial
Triulzi, Tiziana; Bianchini, Giampaolo; Di Cosimo, Serena; Pienkowski, Tadeusz; Im, Young-Hyuck; Bianchi, Giulia Valeria; Galbardi, Barbara; Dugo, Matteo; de Cecco, Loris; Tseng, Ling-Ming; Liu, Mei-Ching; Bermejo, Begona; Semiglazov, Vladimir; Viale, Giul
MOLECULAR ONCOLOGY
(2021)
DOI /
10.1002/1878-0261.13141
Mentions
8
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pembrolizumab plus eribulin in hormone receptore-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase II trial
Perez-Garcia, Jose M.; Llombart-Cussac, Antonio; Cortes, Maria G.; Curigliano, Giuseppe; Lopez-Miranda, Elena; Alonso, Jose L.; Bermejo, Begona; Calvo, Lourdes; Caranana, Vicente; de la Cruz Sanchez, Susana; Vazquez, Raul M.; Prat, Aleix; Borrego, Manuel R
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.02.028
Mentions
8
Twitter
0
Wikipedia
0
News
0
Policy
Article
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I; Andersen, J.; Passos-Coelho, J. L.; Gil Gil, M.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; de la Pena, L.; Xu, N.; Wongchenko, M.; Shi, Z.; Singel, S. M.; Isakoff, S. J.
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdz177
Bronze
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Critically short telomeres and toxicity of chemotherapy in early breast cancer
Quintela-Fandino, Miguel; Soberon, Nora; Lluch, Ana; Manso, Luis; Calvo, Isabel; Cortes, Javier; Moreno-Anton, Fernando; Gil-Gil, Miguel; Martinez-Janez, Noelia; Gonzalez-Martin, Antonio; Adrover, Encarna; de Andres, Raquel; Vinas, Gemma; Llombart-Cussac,
ONCOTARGET
1949-2553 (2017)
DOI /
10.18632/oncotarget.15592
Green submitted, Green published, Gold
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
Tormo, Eduardo; Ballester, Sandra; Adam-Artigues, Anna; Burgues, Octavio; Alonso, Elisa; Bermejo, Begona; Menendez, Silvia; Zazo, Sandra; Madoz-Gurpide, Juan; Rovira, Ana; Albanell, Joan; Rojo, Federico; Lluch, Ana; Eroles, Pilar
SCIENTIFIC REPORTS
2045-2322 (2019)
DOI /
10.1038/s41598-019-41472-y
Gold, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results?
Alarcon, Marina; Buch, Elvira; Julve, Ana; Hernandorena, Marta; Tajahuerce, Marcos; Rodriguez, Hector; Bermejo, Begona; Ramirez, Judith; Burgues, Octavio; Diaz, Sandra; Alcala, Gara M.; Ortega, Joaquin
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
1479-666X (2021)
DOI /
10.1016/j.surge.2021.01.013
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
Loibl, Sibylle; de la Pena, Lorena; Nekljudova, Valentina; Zardavas, Dimitrios; Michiels, Stefan; Denkert, Carsten; Rezai, Mahdi; Bermejo, Begona; Untch, Michael; Lee, Soo Chin; Turri, Sabine; Urban, Patrick; Kuemmel, Sherko; Steger, Guenther; Gombos, Andr
EUROPEAN JOURNAL OF CANCER
0959-8049 (2017)
DOI /
10.1016/j.ejca.2017.08.020
Green accepted
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver
Hruschka, Natascha; Kalisz, Mark; Subijana, Maria; Grana-Castro, Osvaldo; Del Cano-Ochoa, Francisco; Brunet, Laia Pare; Chernukhin, Igor; Sagrera, Ana; de Reynies, Aurelien; Kloesch, Bernhard; Chin, Suet-Feung; Burgues, Octavio; Andreu, David; Bermejo, Beg
ONCOGENE
0950-9232 (2020)
DOI /
10.1038/s41388-020-1376-3
Green published, Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
Baselga, Jose; Zamagni, Claudio; Gomez, Patricia; Bermejo, Begona; Nagai, Shigenori E.; Melichar, Bohuslav; Chan, Arlene; Mangel, Laszlo; Bergh, Jonas; Costa, Frederico; Gomez, Henry L.; Gradishar, William J.; Hudis, Clifford A.; Rapoport, Bernardo L.; Roc
CLINICAL BREAST CANCER
1526-8209 (2017)
DOI /
10.1016/j.clbc.2017.05.006
Green accepted
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study
Ruiz-Borrego, Manuel; Guerrero-Zotano, Angel; Bermejo, Begona; Ramos, Manuel; Cruz, Josefina; Manuel Baena-Canada, Jose; Cirauqui, Beatriz; Rodriguez-Lescure, Alvaro; Alba, Emilio; Martinez-Janez, Noelia; Munoz, Montserrat; Antolin, Silvia; Alvarez, Isabel
BREAST CANCER RESEARCH AND TREATMENT
0167-6806 (2019)
DOI /
10.1007/s10549-019-05296-8
